Synergistic antifungal activity of 5-fluorocytosine (5-FC) and amphotericin B was studied using an abbreviated checkerboard titration scheme. 
graded increments of amphotericin B (1.0. 0.5, 0.1, 0.05, and 0.01 ,ug/ml) in buffered yeast nitrogen base. A limited number of experiments were performed using expanded dual titration checkerboard schemes and growth curve studies. Forty-eight isolates of yeastlike organisms were tested; two were inhibited by the buffer system. Evidence of synergy, as indicated by a fourfold or greater reduction of the minimal inhibitory concentration of 5-FC in the presence of subinhibitory concentrations of amphotericin B, was seen with 11 of 46 isolates, or 24%, at the fungistatic level and with three isolates, or 7% at the fungicidal level. Indifferent results were obtained for 44 and 74% of the isolates, respectively, at the fungistatic and fungicidal levels. Antagonism was observed with three isolates.
In 1971 Medoff et al. reported on the apparent synergistic antifungal activity of combinations of 5-fluorocytosine (5-FC) and amphotericin B against yeastlike organisms (5) . Although the validity of these findings was questioned by some investigators, they nonetheless stimulated others to examine the possible therapeutic applications of this effect both in vivo in experimentally infected animals (2, 8, 10) and clinically in naturally acquired human cryptococcosis (I. L. Garriques, M. A. Sande, J. P. Utz, G. L. Mandell, J. F. Warner, R. F. McGehee, and S. Shadomy. Abstr. Prog. Intersci. Conf. Antimicrob. Agents Chemother., 13th, Washington, D.C., Abstr. 239, 1973) .
Previously, we presented preliminary results from in vitro studies with combinations of 5-FC and amphotericin B which, to a degree, confirmed the original report of Medoff et al. (5) Candida tropicalis and C. (Fig. 4) showed that while neither drug alone was totally inhibitory, the combination was partially so.
Candida sp. One isolate of C. albicans was inhibited by the buffer system. Three isolates of C. albicans and one of C. parapsilosis were totAlly resistant to 5 ug/ml, MFC > 100 Aig/ml; amphotericin B ,og/ml, MFC > 1.0 og/ml. )bologram second drug, strikes toward the middle ground I in Fig. 5 . between the two above opinions. i was seen
In our earlier studies with 5-FC and C. ]dida spe-neoformans, we noted that this drug was nearly of this oc-totally inactive in vitro in the presence of such )sis resist-common ingredients of nonsynthetic culture ml. In the media as peptones, yeast extracts, and Casatration of mino Acids (9) . This was attributed to competiis reduced tive inhibition by cytosine. This observation decreases was confirmed in the elucidation of the mode of ich of C. action of 5-FC in susceptible yeasts. In brief, silosis. No 5-FC enters yeast cells via a permease enzyme, i with one is deaminated for 5-fluorouracil intracellularly seen with and then enters the pathway for synthesis of iidence of ribonucleic acid (8) . This pattern can be anCandida tagonized by the natural pyrimidine analogue as well as by other purines, pyrimidines, and nucleosides at both the uptake and deamination steps. Thus, it was most surprising when Medto define. off et al. first reported that subinhibitory conmbination centrations of amphotericin B and 5-FC comthe effect bined in a nonsynthetic medium containing eater than antagonists to the latter drug were synergistic in h the two inhibiting growth of C. albicans and C.
bars to be neoformans (5 (7), it is restricted in that it is not demonstrable with all isolates of yeastlike organisms. This is borne out by the fact that in our study evidence of synergy at the fungistatic level was obtained with only 24% of 46 isolates and at the fungicidal level with only' 7%. In contrast, indifference was seen with 44 and 74% of the isolates, respectively, at the fungistatic and fungicidal levels. Second, we observed synergy most frequently in isolates characterized by a moderate degree of resistance to 5-FC alone, i.e., with MIC values of 25 to 50,ug/ml. This finding is similar to that of Polak who reported synergy between the two drugs in "partially 5-FC resistant" isolates of Candida (7) . The most plausible explanation for synergistic potentiation of 5-FC by amphotericin B in these organisms, as suggested by Medoff et al. (6) , would be the increased penetration of the first drug as a result of changes in membrane permeability induced by the second. In such isolates, one can postulate the presence of either a modified permease system or one which does not recognize 5-FC together with functional deaminase and kinase systems. Further, in those isolates which remain totally resistant to the combined drugs, one can postulate either the absence of a functional deaminase or the failure of 5-fluorouracil to enter the pathway for ribonucleic acid synthesis via uridine kinase. Antagonism is more difficult to explain but it is reasonable to believe that this may also be a result of modification in membrane function induced by amphotericin B.
